Selective induction of human beta-defensin mRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells

Oral Microbiology and Immunology

Volumn 18, Issue 6, 2003, Pages 359-363

  Feucht, E C ^a   DeSanti, C L ^b   Weinberg, Aaron ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Actinobacillus actinomycetemcomitans; Beta defensins; Cell culture

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOUTH MUCOSA; PROTEIN INDUCTION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; CELL LINE; CELL SURVIVAL; COLONY COUNT, MICROBIAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LIPOPOLYSACCHARIDES; MOUTH MUCOSA; RNA, MESSENGER;

EID: 0242642285     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-0055.2002.00097.x     Document Type: Article

References (25)

1. Abiko Y, Mitamura J, Nishimura M, et al. Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 1999: 143: 37-42.
2. Ali RS, Falconer A, Ikram M, et al. Expression of the peptide antibiotics, human beta-defensin 1 and human beta-defensin 2 in normal human skin. J Invest Dermatol 2001: 117: 106-111.
3. Becker MN, Diamond G, Verghese MW, et al. CD14-dependent LPS induced beta defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 2000: 275: 29731-2936.
4. Diamond G, Kaiser V, Rhodes J, et al. Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun 2000: 68: 113-119.
5. NK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000: 20: 1436-1447.
6. Feng Z, Weinberg A. Manuscript in preparation.
7. Ganz T. Defensins and host defense. Science 1999: 286: 420-421.
8. Garcia JRC, Jaumann F, Schulz S, et al. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Cell Tissue Res 2001: 306: 257-264.
9. Garcia JRC, Krause A, Schulz S, et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001: 15: 1819-1821.
10. Harder J, Meyer-Hoffert U, Teran LM, et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin 2 in respiratory epithelium. Am J Respir Cell Mol Biol 2000: 22: 714-721.
11. Harder J, Bartels J, Christophers E, et al. Isolation and characterization of human beta-defensin 3, a novel human inducible peptide antibiotic. J Biol Chem 2001: 276: 5707-5713.
12. Hritz M, Fisher E, Demuth DR. Differential regulation of the leukotoxin operon in highly leukotoxic and minimally leukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun 1996: 64: 2724-2729.
13. Krisanaprakornkit S, Kimball JR, Weinberg A, et al. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: Multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000: 68: 2907-2915.
14. Krisanaprakornkit S, Kimball JR, Dale BA. Regulation of human beta-defensin 2 in gingival epithelial cells: The involvement of mitogen-activated protein kinase pathways, but not the nuclear factor kappa-B transcription factor family. J Immunol 2002: 168: 316-324.
15. McCarthy LC, Kavies KJ, Campbell DA. Pharmocogenetics in diverse ethnic populations-implications for drug discovery and development. Pharmacogenomics 2002: 3: 493-506.
16. Moser C, Weiner DJ, Lysenko E, et al. Beta-defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 2002: 70: 3068-3072.
17. Pande P, Mathur M, Shukla NK, et al. pRB and p16 protein alterations in human oral tumorigenesis. Oral Oncol 1998: 34: 396-403.
18. Sawaki K, Mizukawa N, Yamaai T, et al. High concentrations of beta-defensin 2 in oral squamous cell carcinoma. Anticancer Res 2002: 22: 2103-2107.
19. Schutte BC, McCray PB. Beta-defensins in lung host defense. Annu Rev Physiol 200: 64:709-748.
20. Singh PK, Jia HP, Wiles K, et al. Production of beta-defensins by human airway epithelium. Proc Natl Acad Sci USA 1998: 95: 14961-14966.
21. Suzuki N, Nakano Y, Yoshida Y, et al. Identification of Actinobacillus actinomycetemcomitans serotypes by multiplex PCR. J Clin Microbiol 2001: 39: 2002-2005.
22. Tsutsumi-Ishii Y, Nagaoka I. KF-kappa B-mediated transcriptional regulation of human beta-defensin-2 gene following lipopolysaccharide stimulation. J Leukoc Biol 2002: 71: 154-162.
23. Wada A, Ogushi K, Kimura T, et al. Helicobacter pylori-mediated transcriptional regulation of the human beta-defensin 2 gene requires NF-κB. Cell Microbiol 2001: 3: 115-123.
24. Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 1998: 9: 399-414.
25. Wolff B, Naumann M. INK4 cell cycle inhibitors direct transcriptional inactivation of NF-κB. Oncogene 1999: 18: 2663-2666.